TESARO Inc (NASDAQ:TSRO)
During the Trading Day
| 35.00 |  +0.30 / +0.86% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 34.80 |  -0.2036 / -0.58% |
Volume: 200.00 |
Latest TSRO News | Press Releases
No recent news for TESARO Inc.
Today’s Trading
| Previous close | 34.70 |
| Today’s open | 34.00 |
| Day’s range | 34.00 - 35.41 |
| Volume | 283,940 |
| Average volume (3 months) | 190,670 |
| Market cap | $1.1B |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | -633.57% |
| Earnings growth (this year) | +41.96% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 8.14 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| INFIInfinity Pharmaceuti... | +1.24 | +5.36% |
| PDLIPDL BioPharma Inc | +0.09 | +1.09% |
| SRPTSarepta Therapeutics... | +1.62 | +4.46% |
| ACADACADIA Pharmaceutica... | +0.37 | +2.76% |
Data as of 4:00pm ET, 05/23/2013
Financials
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | -$0.61 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$61.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Director & Chief Scientific Officer Mary Lynne Hedley, PhD |
Chief Executive Officer & Director Leon O. Moulder, Jr., MBA |
Corporate headquarters Waltham, Massachusetts |
Forecasts
